Search - tctmd.com

Displaying 41 - 60 of 61

Sort: Relevancy | Date

Presentation TCT 2018

Atrial Fibrillation and ACS/PCI: The End of Triple Therapy?

Presenter: Jeroen J. Bax, Stephan Windecker

September 21, 2018

Presentation TCT 2018

Revascularization in Cardiogenic Shock: New Insights

Presenter: Jeroen J. Bax, Stephan Windecker, Holger Thiele

September 21, 2018

Presentation TCT 2018

What is the Future of Bioresorbable Scaffolds?

Presenter: Jeroen J. Bax, Stephan Windecker, Michael Haude

September 21, 2018

Presentation TCT 2018

The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease

Presenter: Jeroen J. Bax, Stephan Windecker, Robert A. Byrne

September 21, 2018

Presentation TCT 2018

Novel Hemodynamic Assessment Parameters and Intracoronary Imaging to Optimize PCI Outcomes

Presenter: Jeroen J. Bax, Stephan Windecker, Javier Escaned

September 21, 2018

Presentation TCT 2018

Beyond ORBITA: The Role of PCI in Stable Ischemic CAD

Presenter: Jeroen J. Bax, Stephan Windecker, Adrian P. Banning

September 21, 2018

Presentation TCT 2018

CT Angiography Versus Ischemia Testing for Detection of Coronary Artery Disease

Presenter: Jeroen J. Bax, Stephan Windecker

September 21, 2018

Presentation The Structural Heart Disease Summit 2018

Other Transcatheter TR Device Therapies Coaptation Spacers and Valve Replacement - Should Be Added to the Armamentarium

Presenter: Susheel K. Kodali

June 21, 2018

Presentation

Does Tricuspid Leaflet Grasping Make Sense As a Primary or Adjunctive TR Therapy?

Presenter: Georg Nickenig

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Does Tricuspid Leaflet Grasping Make Sense As a Primary or Adjunctive TR Therapy?

Presenter: Georg Nickenig

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

One-stop Shopping: Once TMVR Is Refined, Clearly the Preferred Therapy for Most MR Patients

Presenter: Martin B. Leon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Leaflet Chordal Suspension for Primary MR Will Importantly Augment the Surgical/Interventional Toolbox

Presenter: David H. Adams

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Transcatheter Mitral Annuloplasty Devices Will Be the "Centerpiece" in the Future

Presenter: Steven F. Bolling

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cant Beat Safety and Simplicity: Transcatheter Leaflet Approximation Technologies Will Continue to Dominate

Presenter: Ted Feldman

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

NO: The Data Are Weak and the Costs Are Prohibitive!

Presenter: John K. Forrest

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

YES: Review of ALL the Data and Common Sense Tell the Story!

Presenter: Axel Linke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cedars-Sinai Medical Center (USA)

Presenter: Tarun Chakravarty

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Erasmus University (The Netherlands)

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Ulm University (Germany)

Presenter: Julia Seeger

June 21, 2018

News Daily News

Costs of Atherosclerotic CVD Cripple Low-Income Families, Even With Insurance

Shelley Wood

April 06, 2018

Advertisement

Atrial Fibrillation and ACS/PCI: The End of Triple Therapy?

Revascularization in Cardiogenic Shock: New Insights

What is the Future of Bioresorbable Scaffolds?

The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease

Novel Hemodynamic Assessment Parameters and Intracoronary Imaging to Optimize PCI Outcomes

Beyond ORBITA: The Role of PCI in Stable Ischemic CAD

CT Angiography Versus Ischemia Testing for Detection of Coronary Artery Disease

Other Transcatheter TR Device Therapies Coaptation Spacers and Valve Replacement - Should Be Added to the Armamentarium

Does Tricuspid Leaflet Grasping Make Sense As a Primary or Adjunctive TR Therapy?

Does Tricuspid Leaflet Grasping Make Sense As a Primary or Adjunctive TR Therapy?

One-stop Shopping: Once TMVR Is Refined, Clearly the Preferred Therapy for Most MR Patients

Leaflet Chordal Suspension for Primary MR Will Importantly Augment the Surgical/Interventional Toolbox

Transcatheter Mitral Annuloplasty Devices Will Be the "Centerpiece" in the Future

Cant Beat Safety and Simplicity: Transcatheter Leaflet Approximation Technologies Will Continue to Dominate

NO: The Data Are Weak and the Costs Are Prohibitive!

YES: Review of ALL the Data and Common Sense Tell the Story!

Cedars-Sinai Medical Center (USA)

Erasmus University (The Netherlands)

Ulm University (Germany)

Costs of Atherosclerotic CVD Cripple Low-Income Families, Even With Insurance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content